Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors
Clinical trial NCT01921855 · COMPLETED
Trial details
- NCT number
- NCT01921855
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.